Functional mapping of rbOCT1 and rbOCT2 activity in the S2 segment of rabbit proximal tubule

被引:27
作者
Kaewmokul, S
Chatsudthipong, V
Evans, KK
Dantzler, WH
Wright, SH [1 ]
机构
[1] Univ Arizona, Coll Med, Dept Physiol, Tucson, AZ 85724 USA
[2] Mahidol Univ, Dept Physiol, Bangkok 10700, Thailand
关键词
organic cation; transport; tetraethylammonium; cimetidine; kidney;
D O I
10.1152/ajprenal.00112.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
A strategy was developed to determine the distribution of activity mediated by the organic cation (OC) transporters OCT1 and OCT2 in rabbit renal proximal tubule (RPT). Both transporters displayed similar affinities for tetraethylammonium (TEA; in CHO-K1 cells, TEA concentrations that resulted in half-maximal transport were 19.9 and 34.5 muM for OCT1 and OCT2, respectively). Similarly, some OCs showed little capacity to discriminate between the two processes (IC(50) values for ephedrine of 13.6 and 24.2 muM for OCT1 and OCT2, respectively). However, OCT2 had a higher affinity for cimetidine and [2-(4-nitro-2,1,3-benzoxadiazol-7-yl) aminoethyl] trimethylammonium (NBD-TMA; 1.3 and 1.4 muM, respectively) than did OCT1 (97.3 and 108 muM, respectively). Conversely, OCT1 had a higher affinity for tyramine and pindolol than did OCT2 (21.2 and 2.4 vs. 361 and 50 muM, respectively). We designated these as "discriminatory inhibitors" and used them to determine the relative contribution of OCT1 and OCT2 for TEA transport in single S2 segments of rabbit RPT. Cimetidine and NBD-TMA were high-affinity inhibitors of TEA transport in S2 segments (median IC(50) values of 12.3 and 1.4 muM, respectively); in comparison, tyramine and pindolol were low-affinity inhibitors ( 265 and 69.3 muM, respectively). These IC(50) values were sufficiently close to those for OCT2 to support the conclusion that TEA transport in the S2 segment of rabbit RPT is dominated by OCT2. However, the profile of inhibition of tyramine ( an OCT1-selective substrate) transport in single S2 segments indicated that, despite a comparatively low level of expression, OCT1 can play a dominant role in the uptake of selected OC substrates.
引用
收藏
页码:F1149 / F1159
页数:11
相关论文
共 38 条
[1]   Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1 [J].
Arndt, P ;
Volk, C ;
Gorboulev, V ;
Budiman, T ;
Popp, C ;
Ulzheimer-Teuber, I ;
Akhoundova, A ;
Koppatz, S ;
Bamberg, E ;
Nagel, G ;
Koepsell, H .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 281 (03) :F454-F468
[2]   The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization [J].
Barendt, WM ;
Wright, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22491-22496
[3]   NBD-TMA: a novel fluorescent substrate of the peritubular organic cation transporter of renal proximal tubules [J].
Bednarczyk, D ;
Mash, EA ;
Aavula, BR ;
Wright, SH .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 440 (01) :184-192
[4]   Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1 [J].
Busch, AE ;
Quester, S ;
Ulzheimer, JC ;
Waldegger, S ;
Gorboulev, V ;
Arndt, P ;
Lang, F ;
Koepsell, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) :32599-32604
[5]   Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases [J].
Çetinkaya, I ;
Ciarimboli, G ;
Yalçinkaya, G ;
Mehrens, T ;
Velic, A ;
Hirsch, JR ;
Gorboulev, V ;
Koepsell, H ;
Schlatter, E .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 284 (02) :F293-F302
[6]   Role of organic cation transporters in the renal secretion of nucleosides [J].
Chen, R ;
Nelson, JA .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (02) :215-219
[7]   BRUSH-BORDER TEA TRANSPORT IN INTACT PROXIMAL TUBULES AND ISOLATED MEMBRANE-VESICLES [J].
DANTZLER, WH ;
BROKL, OH ;
WRIGHT, SH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (02) :F290-F297
[8]  
Dresser MJ, 2000, J PHARMACOL EXP THER, V292, P1146
[9]  
Goralski KB, 1999, J PHARMACOL EXP THER, V290, P295
[10]   Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate [J].
Gorboulev, V ;
Volk, C ;
Arndt, P ;
Akhoundova, A ;
Koepsell, H .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1254-1261